🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s CNMD Holdings & Trades

First Buy
Q2 2013
Duration Held
35 Quarters
Largest Add
Q3 2025
+83,418 Shares
Current Position
30,208 Shares
$1.4 M Value

Paul Tudor Jones's CNMD Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 30,208 shares of CONMED Corporation (CNMD) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 35 quarters.

Based on 13F filings, Paul Tudor Jones has maintained a strategic position in CNMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 83,418 shares. Largest reduction occurred in Q1 2026, reducing 82,089 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's CONMED Corporation (CNMD) Holding Value Over Time

Track share changes against reported price movement

Quarterly CONMED Corporation (CNMD) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +6,905 Add 29.63% 30,208 $46.23
Q2 2026 +23,303 New Buy 23,303 $32.73
Q1 2026 -82,089 Sold Out 0 $0.00
Q4 2025 -42,855 Reduce 34.30% 82,089 $40.60
Q3 2025 +83,418 Add 200.88% 124,944 $47.03
Q2 2025 +41,526 New Buy 41,526 $52.08
Q4 2024 -49,285 Sold Out 0 $0.00
Q3 2024 -59,036 Reduce 54.50% 49,285 $71.92
Q2 2024 -5,110 Reduce 4.50% 108,321 $69.32
Q1 2024 +36,187 Add 46.85% 113,431 $80.08
Q4 2023 -1,182 Reduce 1.51% 77,244 $109.51
Q3 2023 +62,677 Add 397.97% 78,426 $100.85
Q2 2023 -48,726 Reduce 75.57% 15,749 $135.89
Q1 2023 +11,274 Add 21.19% 64,475 $0.10
Q4 2022 -28,573 Reduce 34.94% 53,201 $0.09
Q3 2022 +8,944 Add 12.28% 81,774 $80.17
Q2 2022 +47,650 Add 189.24% 72,830 $95.76
Q1 2022 +25,180 New Buy 25,180 $148.53
Q4 2020 -4,511 Sold Out 0 $0.00
Q3 2020 -12,351 Reduce 73.25% 4,511 $78.70
Q2 2020 -7,650 Reduce 31.21% 16,862 $72.00
Q1 2020 +14,432 Add 143.17% 24,512 $57.28
Q4 2019 +4,721 Add 88.09% 10,080 $111.81
Q3 2019 +5,359 New Buy 5,359 $96.10
Q1 2016 -5,000 Sold Out 0 $0.00
Q4 2015 -1,500 Reduce 23.08% 5,000 $44.00
Q3 2015 +6,500 New Buy 6,500 $47.69
Q1 2015 -8,180 Sold Out 0 $0.00
Q4 2014 -16,462 Reduce 66.80% 8,180 $44.99
Q3 2014 +2,272 Add 10.16% 24,642 $36.85
Q2 2014 -2,553 Reduce 10.24% 22,370 $44.17
Q1 2014 +17,623 Add 241.41% 24,923 $43.45
Q4 2013 -3,800 Reduce 34.23% 7,300 $42.47
Q3 2013 -16,700 Reduce 60.07% 11,100 $33.96
Q2 2013 +27,800 Add 0.00% 27,800 $31.22

Paul Tudor Jones's CONMED Corporation Investment FAQs

Paul Tudor Jones first purchased CONMED Corporation (CNMD) in Q2 2013, acquiring 27,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held CONMED Corporation (CNMD) for 35 quarters since Q2 2013.

Paul Tudor Jones's largest addition to CONMED Corporation (CNMD) was in Q3 2025, adding 124,944 shares worth $5.88 M.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 30,208 shares of CONMED Corporation (CNMD), valued at approximately $1.4 M.

As of the Q3 2026 filing, CONMED Corporation (CNMD) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in CONMED Corporation (CNMD) was 124,944 shares, as reported at the end of Q3 2025.